COMMUNIQUÉS West-GlobeNewswire

Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018

01/02/2018 - 22:05

MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ: CORI ) today announced that it will report financial results for the first quarter ended December 31, 2017 on February 8, 2018 [...]

HCi Viocare Comments on Recent Stock Volume and Price Increase

01/02/2018 - 22:01

GLASGOW, SCOTLAND , Feb. 01, 2018 (GLOBE NEWSWIRE) -- HCi Viocare has been advised of a significant increase in the share price and trading volume of the Company's shares beginning Wednesday January 31, 2018. The [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/02/2018 - 22:01

BOSTON, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

athenahealth Reports Fourth Quarter and Full Year 2017 Results

01/02/2018 - 22:01

Q4 2017 Financial Results 14% Revenue Growth Over Fourth Quarter of 2016 GAAP Operating Income of $38.7 million Non-GAAP Adjusted Operating Income of $77.6 million GAAP Net Income of $31.6 million, or $0.78 Per Diluted [...]

CymaBay Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

01/02/2018 - 22:01

NEWARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Women In Bio Announces Jane Wasman Appointed Chair of Sellas Life Sciences’ Board of Directors

01/02/2018 - 22:01

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, announced today the [...]

Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results

01/02/2018 - 22:00

MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) today announced financial results for its fourth quarter and year ended December 31, 2017. Product, service [...]

Crawford Healthcare Inc. Receives New Innovative Technology Contract from Vizient, Inc. for Touchless Care Zinc Protectant Spray

01/02/2018 - 21:46

DOYLESTOWN, Pa. and CHESHIRE, United Kingdom, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Crawford Healthcare announced its Touchless Care Zinc Protectant Spray has received an Innovative Technology contract from Vizient, Inc . [...]

Alpha Pro Tech, Infection Control Segment, N-95 Facemask Product Availability Update Seasonal Influenza

01/02/2018 - 20:00

Nogales, Ariz., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

CROSSJECT : La FDA attribue à ZENEO® Midazolam le statut de médicament orphelin

01/02/2018 - 19:42

Communiqué de Presse La FDA attribue à ZENEO® Midazolam le statut de médicament orphelin Dijon, le 1 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

HempAmericana Announces Interview Ahead of Full-Scale CBD Oil Production Activity

01/02/2018 - 18:23

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce a new interview with Company CEO, Salvador Rosillo, from Uptick [...]

Insider tradings

01/02/2018 - 17:47

Nasdaq Copenhagen 1 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]

NICOX : Number of voting rights as of January 31, 2018

01/02/2018 - 17:45

Nicox SA Société anonyme with a registered capital of € 29,459,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On February 1, 2018, MONTHLY PUBLICATION OF THE [...]

NICOX : Nombre de droits de vote au 31 janvier 2018

01/02/2018 - 17:45

Nicox SA Société anonyme au capital de 29 459 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1er février 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]

New Chief Human Resources Officer Joins Corizon Health

01/02/2018 - 16:50

BRENTWOOD, Tenn., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Carolyn Schneider has joined Corizon Health as its Chief Human Resources Officer, CEO Steve Rector announced. “Carolyn’s extensive experience in integrating workforces [...]

Alder BioPharmaceuticals, Inc. Announces Closing of $250 Million of 2.50% Convertible Senior Notes Due 2025

01/02/2018 - 16:46

BOTHELL, Wash., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]

Insider tradings

01/02/2018 - 16:32

Nasdaq Copenhagen 1 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]

Intercept Announces Updated U.S. Prescribing Information for Ocaliva® (obeticholic acid) to Reinforce Appropriate Dosing in PBC Patients with Advanced Cirrhosis

01/02/2018 - 15:46

NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction

01/02/2018 - 15:32

LOS ANGELES, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced [...]